Mixed Dementia: Mixed dementia reflects overlapping AD and cerebrovascular pathology, including A plaques, tau deposition, and ischemic changes (Desta, 2021), ischemic changes (Chong et al., 2019)
The Effect of L-Carnitine Additive During In Vitro Maturation on the Vitrification of Pig Oocytes
A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist
Methods 3T3-L1 preadipocytes differentiated in the presence of varying concentrations of glucose (25, 45, 65, 85, and 105 mM) were assessed for adipogenesis using AdipoRed (Lonza) assay
While healthy lifestyle changes remain a cornerstone of our approach, semaglutide GLP-1 provides an advanced option that targets the underlying physiological drivers of obesity, offering our patients a real opportunity to reset their weight set point and achieve lasting results
It is proposed that this disturbance in carnitine homeostasis is reflective of a reduction in carnitine palmitoyltransferase-I (CPT-I) activity, possibly a result of the accumulation of omega-6 fatty acids previously observed in this patient population